These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S. Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [Abstract] [Full Text] [Related]
6. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Miyamoto M, Manabe N, Haruma K. Intern Med; 2010 Jan; 49(15):1469-76. PubMed ID: 20686276 [Abstract] [Full Text] [Related]
9. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. Ranaldo N, Losurdo G, Iannone A, Principi M, Barone M, De Carne M, Ierardi E, Di Leo A. Cell Death Dis; 2017 Sep 07; 8(9):e3040. PubMed ID: 28880273 [Abstract] [Full Text] [Related]
10. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring. Kawamura O, Hosaka H, Shimoyama Y, Kawada A, Kuribayashi S, Kusano M, Yamada M. Digestion; 2015 Sep 07; 91(1):19-25. PubMed ID: 25632912 [Abstract] [Full Text] [Related]
15. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S. World J Gastroenterol; 2012 Aug 28; 18(32):4363-70. PubMed ID: 22969200 [Abstract] [Full Text] [Related]
16. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Akiyama J, Hosaka H, Kuribayashi S, Moriyasu S, Hisada Y, Okubo H, Watanabe K, Imbe K, Nagata N, Kojima Y, Yokoi C, Uemura N, Shimoyama Y, Kawamura O, Yamada M, Kusano M. Digestion; 2020 Aug 28; 101(2):174-183. PubMed ID: 30897577 [Abstract] [Full Text] [Related]
18. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. Luo X, Guo XX, Wang WF, Peng LH, Yang YS, Uedo N. World J Gastroenterol; 2016 Apr 14; 22(14):3845-51. PubMed ID: 27076770 [Abstract] [Full Text] [Related]
19. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study. Desjardin M, Luc G, Collet D, Zerbib F. Neurogastroenterol Motil; 2016 Jan 14; 28(1):146-52. PubMed ID: 26526815 [Abstract] [Full Text] [Related]
20. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Stefanidis G, Viazis N, Kotsikoros N, Tsoukalas N, Lala E, Theocharis L, Fassaris A, Manolakopoulos S. Dis Esophagus; 2017 Feb 01; 30(3):1-8. PubMed ID: 27868281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]